ArticleScientific reports2026
Phenotype-specific white matter microstructural alterations and their clinical correlates in Wilson disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wilson disease (WD) is a genetic disorder of copper metabolism that leads to progressive brain damage, yet the microstructural mechanisms underlying white matter alterations remain insufficiently understood. Diffusion tensor imaging provides limited biological specificity and is sensitive to free water contamination. Therefore, we applied neurite orientation dispersion and density imaging to characterize white matter microstructure and its clinical relevance in 30 patients with WD, including neurological and hepatic phenotypes, and 30 matched healthy controls. We demonstrate widespread, phenotype-specific microstructural alterations, with reductions in neurite density and orientation dispersion accompanied by increased extracellular volume fraction and diffusivity metrics (mean, axial, and radial diffusivity) in neurological WD and isolated increased isotropic volume fraction without abnormalities in conventional diffusion metrics in hepatic WD across major white matter tracts. These patterns provide a coherent explanation for previously inconsistent fractional anisotropy findings. Reduced neurite density was associated with greater neurological impairment and lower cognitive performance, particularly in processing speed and visual attention. Together, these findings highlight neurite density as a potential marker of clinically relevant white matter disruption and reveal distinct microstructural signatures across WD phenotypes, consistent with differential underlying mechanisms and a potential progression from free water-related alterations to axonal degeneration. Advanced diffusion imaging thus enables a more specific characterization of white matter pathology and supports linking microstructural alterations to clinical outcomes in neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.